The validity of monitoring the control of diabetes with random blood glucose testing
Keywords:
Diabetes, glycaemic control, random blood glucose, glycated haemoglobin, clinical decision making
Abstract
It is important to decide if a patient with diabetes has good glycaemic control in order to guide treatment and to offer behaviour change counselling. Currently, determining random blood glucose (RBG) is usually carried out in primary care in the public sector to make this decision. This study investigates the validity of these decisions. Retrospective data from a district hospital setting were used to analyse the correlation between glycated haemoglobin (HbA1c) and RBG, the best predictive value of RBG, and its predictive properties. The best value of RBG to predict control (HbA1c ≤ 7%) was 9.8 mmol/l. However, this threshold only gave a sensitivity of 77% and a specificity of 75%. Clinicians would be wrong 23% of the time when using RBG to determine glycaemic control. Attempts should be made to make HbA1c more available for clinical decision-making. Point-of-care testing for HbA1c should be considered.
Published
2013-09-19
Section
Scientific letters
By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the South African Academy of Family Physicians. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.